Product Detail
Scopolamine
Homatropine Hydrobromide API
Stock Status: In Stock
Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Category
API
API Family
Homatropine Hydrobromide
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
CAT No. CS-T-61247
CAS No. 51-34-3
Research Use
Scopolamine Product Information
Scopolamine is listed under API. It is associated with Homatropine Hydrobromide and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-61247.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Scopolamine
CAS No.
51-34-3
CAT No.
CS-T-61247
Molecular Formula
C₁₇H₂₁NO₄
Molecular Weight
303.35
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(O[C@]1(C[C@]2([H])N(C)[C@]([C@]3([H])[C@@]2([H])O3)([H])C1)[H])[C@@](CO)([H])C4=CC=CC=C4
IUPAC Name
(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
Scopolamine is an acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.
Synonyms
Scopolamine (Hyoscine)
Application Notes
Scopolamine is an acetylcholine antagonist. Used in treatment of motion sickness; antiemetic; antispasmodic; mydriatic; preanesthetic medicant.
References
"Brand, J,J,, et al,: Lancet, 2, 232 (1970); Bowles, J,B,, et al,: Anaesthesia, 34, 476 (1979); Clissold, S,P,, et al,: Drugs, 29, 189 (1985); Muhtadi, F,J,, et al,: Anal, Profiles Drug Subs,, 19, 477 (1990)"